Innate Immunity and the Kidney


Objectives

This chapter will:

  • 1.

    Briefly review essential features of innate immunity as the first line of defense against microbial invaders.

  • 2.

    Describe the mechanisms by which the innate immune system rapidly recognizes danger to host viability induced by either infectious or noninfectious tissue injury.

  • 3.

    Detail the role of innate immune functions that enable specific elements of the adaptive immune system to become activated and begin the process of pathogen clearance without collateral damage to the host.

  • 4.

    Enumerate the mechanisms by which the innate immune cell activation is held in check and begins to undergo the active process of resolution of inflammation and tissue repair.

  • 5.

    Review some unique innate immune functions found in the kidney and urinary collecting system.

A Brief History of Discoveries of the Innate and Adaptive Host Immune Responses

The initial recognition of active host defense against microbial pathogens is credited to Élie Ilyich Metchnikoff, who realized amebocytes from starfish would migrate toward foreign invaders and ingest them. He reasoned that such a beneficial host defense would be passed on to higher organisms by Darwinian evolution and would likely be found in humans. He was first to confirm this fact by finding specialized cells in human blood engaged in what he coined to be “phagocytosis.” Metchnikoff gained the support of Louis Pasteur, and he spent the rest of his career at the Pasteur Institute in Paris investigating the role of phagocytic cells in innate host defense. He observed two major types of phagocytic cells: large tissue-based macrophages and smaller circulating “microphages,” now known as neutrophils. Metchnikoff's observations were first scoffed at by his peers and public. George Bernard Shaw's play “The Doctor's Dilemma” was written as a humorous satire of Metchnikoff's ideas.

While the cellular contribution of professional phagocytes to host defense was under study in Paris, a competing school of humoral immunity was championed in Germany. Behring and Kitasato of the Koch Institute in Berlin showed that immune serum from animals that survived an infection, in the absence of cells, could passively protect nonimmune animals. The protective factor, serum antibodies, were discovered in immune serum, along with series of proteins that amplified antibody activity, now recognized as the complement system. This work was conducted primarily by Paul Ehrlich et al. in Germany. Subsequent studies clearly established that humoral immune elements, myeloid cells of the innate immune system, and lymphoid cells of the adaptive immune system collaborate to defend patients from microbial invaders. Appropriately, Metchnikoff and Ehrlich shared the Nobel Prize in medicine in 1908, as recognition of their critical discoveries and as an acknowledgment of the equal importance of humoral and cellular immunity in host defense.

Recently, the Nobel Prize in Physiology and Medicine was shared by three scientists for unraveling the mysteries of innate immune sensing, pattern recognition, and Toll-like receptors (TLRs). In 2011 the Nobel Prize went to Bruce Beutler for discovering TLR4, the long sought-after cellular receptor that recognizes bacterial endotoxin. He shared the prize with Ralph Steinman for his discovery of dendritic cells and Jules Hoffman for developing the basic concepts and identity of the pattern recognition receptors in innate immune activation.

Introduction Into Innate Immunity

The innate immune response can be likened to the rapid response team found in most large hospital systems. This team consists of a specified group of healthcare workers, with a clear set of identifiable skills, and has the responsibility to immediately respond and rescue suddenly ill patients within the hospital. The code team does not know what they will find when they arrive at the patient's room. It may be a plugged endotracheal tube in a patient needing ventilator support, chest pain with a dysrhythmia, someone fallen out of bed with a bumped head, a massive gastrointestinal hemorrhage, an adverse drug reaction with anaphylactic shock, or a myriad of other crises that require immediate attention. The team members must make a rapid assessment of the problem, begin appropriate care, and call in other specialists to assist if necessary. Our innate immune system serves similar functions when our physical barriers to infection have been breached by a traumatic injury to the integument.

Any injury can pose a threat to host survival on two fronts: infection by entry of pathogens from the external environment or exsanguination with loss of the internal milieu from bleeding. The innate immune response system is called into action within minutes by danger signals sent out by sentinel macrophages and soluble pattern recognition receptors such as the mannose-binding lectin and alternative complement pathway. Local generation of chemical signals in the form of chemokines and other chemoattractants is detected by adjacent endothelial cells and circulating neutrophils and platelets to begin the delivery of phagocytic cells and antimicrobial peptides to engage and eliminate any microbial pathogens invading the tissues. Concomitantly, the clotting system is activated when exposed collagen binds to circulating von Willebrand factor (VWF), thereby creating long multimers of VWF to which platelets bind and aggregate. Simultaneously, tissue factor exposed by endothelial membrane disruption initiates the coagulation cascade with fibrin deposition. The innate immune response and coagulation systems are coactivated and coregulated to protect against excessive bleeding and infection. Innate immune sensing of danger is a highly evolved and complex network of cellular and soluble receptor molecules that recognize highly conserved molecular patterns found in essential structures for microorganisms, but not for human cells. These exogenous ligands are referred to collectively as PAMPs (pathogen-associated molecular patterns). However, innate immune signaling is not simply initiated by “self” versus “non-self” recognition. Innate immune receptor molecules also recognize endogenous human pattern molecules leaked from dead or dying cells and elements of ground substances that make up the intercellular matrix. The endogenous pattern molecules released during tissue injury are danger signals detectable by innate immune cells by the same type of pattern-recognition receptors that detect PAMPs. The danger signals from tissue injury are DAMPs, or damage-associated molecular patterns. The most widely recognized pattern recognition receptors of innate immunity are the Toll-like receptors (TLRs) but are not the only receptors that participate in the host response to pathogens. A brief summary of major ligands that make up the PAMPs, DAMPs, and their cellular receptors expressed on immune cells is found in Table 82.1 and detailed, along with the major intracellular signaling pathways, in Fig. 82.1 .

TABLE 82.1
Common PAMPs, DAMPs, and Their Human Innate Immune Receptors
(Modified from Opal SM. Immunologic alterations and the pathogenesis of organ failure in the ICU. Seminars Respir Crit Care. 2011;32[5]:569–580; Beutler B. TLRs and innate immunity. Blood. 2009;113[7]:1399–1407; Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull, Vincent JL. Sepsis and septic shock. Nat Rev Disease Primers. 2016; 2:1–21.)
PAMPs PAMP RECEPTORS DAMPs DAMP RECEPTORS
Lipopolysaccharide (LPS) or endotoxin CD14:MD2:TLR4 HMGB-1 TLR2, TLR4, RAGE
Triacyl lipopeptides TLR1/TLR2 Heat shock proteins TLR2, TLR4
Diacyl lipopeptides TLR6/TLR1 S100 proteins TLR4, RAGE
Muranyl dipeptide from bacteria NOD2 Fibrinogen, fibronectin TLR4
Diaminopimelic acid (gram-negative bacteria) NOD1 Hyaluronan TLR4
RNA viral genomes RLH Biglycans TLR2, TLR4
Lipoteichoic acid (gram-positive bacteria) TLR2 Modified LDL MD2:TLR4
Bacterial flagellin TLR5 Heme TLR4
Single-stranded RNA viruses TLR7/8 Histones TLR4
DNA viruses or bacterial DNA TLR9 Mitochondrial DNA TLR9
Double-stranded RNA viruses TLR3 Nucleosomes TLR4
Fungal mannans TLR4, CLR Neutrophil extracellular traps TLR4
Malarial hemozoin pigment TLR9, NLRs Apoptotic cells C-reactive protein, pentraxins
CLR, C-type lectin receptor; DAMPs, damage-associated molecular patterns; HMGB-1, high-mobility group box 1; LDL, low-density lipoprotein; MD2, myeloid derived 2; NOD2, nucleotide binding oligomerization domain; PAMPs, pathogen-associated molecular patterns; RAGE, receptor for advanced glycated end products; RLH, retinoic acid inducible gene 1–like helicase; TLR, Toll-like receptor.

FIGURE 82.1, Pattern recognition receptors of the human innate immune system and their common pathogen-associated and damage associated ligands. AP-1, Activator protein 1; CARD9, caspase-associated receptor domain containing protein 9; CD, cluster determinant; CpG, cytosine phosphate quanidine motif in DNA; DAMPs, damage-associated molecular patterns; ds, double-stranded; FcγR, crystallizable component of immunoglobulin gamma receptor; HMGB1, high-mobility group box 1; iE-DAP, glutamyl-meso-diaminopimelic acid; IFN, interferon; IRF, interferon response factor; LGP2, laboratory of genetics and physiology 2; LPL, lipoprotein lipase; LPS, lipopolysaccharide; Ly96, lymphocyte antigen 96; MAPK, mitogen-activated protein kinase; MCG, mannose-containing glycoprotein; MCL, mannose-capped lipoarabinomannan; MDA5, melanoma differentiation-associated protein 5; MDP, muramyl dipeptide; Mincle, macrophage inducible C-type lectin; myD88, myeloid differentiation primary response protein 88; NF-κB, nuclear factor in kappa B cells; NIK, NF-κB-induced kinase; NOD, nucleotide binding oligomerization domain; PAMPs, pathogen-associated molecular patterns; RAF1, proto-oncogene serine/threonine protein kinase; RAGE, receptor for advanced glycosylation end products; RIG, retinoic acid–inducible gene 1protein; STING, stimulator of interferon genes; ss, single-stranded; SYK, spleen tyrosine kinase; TDM, trehalose 6,6'dimycolate; TICAM, Toll interleukin-1 receptor domain containing adaptor molecule 1; TLR, Toll-like receptor.

Cellular and Humoral Components of Host Innate Immune Defenses

Cells of the Innate Immune System

Immune cells of the myeloid cell line constitute the major, but not only, cellular components of innate immunity. These cells are called “professional phagocytes,” because this is their primary function, but other epithelial and somatic cells can ingest potential microbial pathogens, along with damaged or dying cells. Myeloid cells encompass circulating progenitor monocytes and tissue resident macrophage cells, including hepatic Kupffer cells, lymph-associated macrophages in spleen and lymph nodes, Langerhans cells in the skin, pulmonary alveolar macrophages, and highly specialized dendritic cells found primarily along mucosal surfaces. Polymorphonuclear cells, or neutrophils, constitute the other myeloid cell line of innate immunity.

Other specialized cells such as M cells differentiate from the epithelial cells of the gastrointestinal tract in response to signals from lymphocytes and make up the specialized gut-associated lymphoid tissues called Peyer's patches. These cells continuously sample the gut luminal environment through active endocytosis. Like professional phagocytes, M cells take up antigens into endosomes, which then fuse with lysosomes to digest the ingested material and present short peptide sequences (epitopes) bound to major histocompatibility complex (MHC) class 2 molecules on their cell surface. Specific clones of T lymphocytes expressing the requisite T cell receptor recognize and respond to the presented epitopes as part of the tightly orchestrated acquired (adaptive) cellular immune response to that antigen. Even classic humoral effector cells of adaptive immunity such as B lymphocytes can phagocytize antibody or complement opsonized microbes, and they possess mechanisms that make them efficient antigen-processing and antigen-presenting cells. They also express the correct antigen-presenting motifs and costimulatory molecules essential to clonally select, activate, and cause clonal proliferation of specific T cells. Activated T lymphocytes also present antigen on class I or II MHC molecules and release proinflammatory cytokines in the process. Thus most cells in the human body possess the capacity to recognize microbes and their toxins at the innate level and initiate and modulate various aspects of the adaptive immune response.

A number of accessory, nonclonal T cell lines, natural killer cells, and even a B cell line are now classified as forming part of the innate immune response found in human immunology ( Table 82.2 ). Coagulation factors are highly coregulated with innate immune cells and form the essential elements to the initial host response to limit injury, preventing blood loss and blocking invasive pathogens after tissue injury.

TABLE 82.2
Cellular Components That Contribute to the Innate Immune Response in Humans
CELL TYPE LIFESPAN IN TISSUES/MAJOR FUNCTIONS ROLE IN INNATE IMMUNITY
Neutrophils T 1/2 12–48 hr; professional phagocyte, express CD14, CD11/CD18, CD64, TLRs, L-selectin, PSGL-1, form NETs Mobile phagocytes ingest and kill pathogens, generate ROI and cytokines, naturally apoptotic
Monocytes/macrophages T 1/2 : days to weeks; monocytes mature to macrophages, professional phagocytes, APC, express CD14, MHC II, CD80/86 Tissue phagocytes sense and phagocytize DAMPs and PAMPs
Produce cytokines and are APCs
Dendritic cells T 1/2 : months to years/Sense pathogens, APCs Express TLRs, MHC II, CD80/86 Present antigens, express cytokine interferons, mucosal immunity
NK cells T 1/2 : months to years/no α/β TCR, MHC 1 restricted, remove virus-infected cells and damaged cells, express CD16, TLRs Cytotoxic to infected cells, innate viral immunity, produce Th1/Th2 cytokines, immune memory
γδ T cells T 1/2 : months to years/ no α/β TCR, recognize phosphoantigens, regulate cell-mediated immunity Recognizes phosphoantigens from bacterial pathogens, regulatory functions in mucosa, granulomas
NKT cells T 1/2 : years/invariant α/β TCR, CD-1d restricted, recognizes glycolipid antigens, express interferons, IL-4 Contributes to host immune response to viral, mycobacterial, and fungal pathogens
B1 cells and ira B cells T 1/2 : years/B cells can function in pathogen detection, express TLRs, cytokines, MHC II , CD80/86, ira B cells secrete GM-CSF Innate response activator (ira) B cells are specialized for antigen detection, GM-CSF production
Treg cells T 1/2 : years/adaptive immune cells that control and inhibit innate immunity; express CD25 and FoxP3, produce TGFβ and IL-10 Major role in tissue repair and in limiting innate immune response
Innate lymphoid cells (ILCs) T 1/2 : months to years/ rapidly activated, proinflammatory cells that express IL-17, IL-5, and interferon γ when exposed to microbes Derived from lymphoid progenitor cells, no TCR or BCR, produce proinflammatory cytokines
Platelets T 1/2 : 7 to 14 days/express P selectin, CD40L, GP1 to bind VWF, GPIIb/IIIa to bind fibrin Activate endothelial cells to promote neutrophil binding
Endothelium T 1/2 : months to years/express P-selectin and E-selectin, CD40, TM, coated with GAGs Maintains vascular integrity, regulates clotting, directs traffic of myeloid cells to infection sites
Epithelium T 1/2 : days/mucosal barrier to pathogens, express TLRs, secrete AMPs, APCs and macrophages sense and clear PAMPs Physical barrier, mucus secretion, AMP secretion, and motility clear potential pathogens
AMP, Antimicrobial proteins; APC, antigen-presenting cell; B cell, bursa-derived lymphocyte; BCR, B cell receptor; CD, cluster determinant; DAMPs, damage-associated molecular patterns; E, endothelial; FoxP3, Forkhead box protein 3; GAGs, glycosaminoglycans; GM-CSF, granulocyte macrophage colony-stimulating factor; GP, glycoprotein; IL, interleukin; L, ligand; MHC, major histocompatibility type 2 antigen; NET, neutrophil extracellular trap; P, platelet; PAMPs, pathogen-associated molecular patterns; PSGL-1, P selectin glycolipid ligand-1; ROI, reactive oxygen intermediates; T cell, thymic-derived lymphocyte; TCR, T cell receptor; TGF, transforming growth factor; Th1, T helper cell type 1; TLR, Toll-like receptor; TM, thrombomodulin; Treg cells, T regulatory cells; VWF, von Willebrand factor.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here